세계의 자동 및 폐쇄형 세포치료 처리 시스템 시장

Global Automated and Closed Cell Therapy Processing Systems Market to Reach US$4.8 Billion by 2030

The global market for Automated and Closed Cell Therapy Processing Systems estimated at US$1.5 Billion in the year 2024, is expected to reach US$4.8 Billion by 2030, growing at a CAGR of 21.2% over the analysis period 2024-2030. Separation Workflow, one of the segments analyzed in the report, is expected to record a 24.2% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Expansion Workflow segment is estimated at 22.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$400.2 Million While China is Forecast to Grow at 19.9% CAGR

The Automated and Closed Cell Therapy Processing Systems market in the U.S. is estimated at US$400.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$732.4 Million by the year 2030 trailing a CAGR of 19.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 19.9% and 18.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.2% CAGR.

Global Automated and Closed Cell Therapy Processing Systems Market - Key Trends & Drivers Summarized

Why Are Automated and Closed Systems Transforming Cell Therapy Processing?

Automated and closed cell therapy processing systems are revolutionizing cell therapy manufacturing by improving efficiency, reducing contamination risks, and ensuring consistent product quality. These systems integrate automated workflows for cell isolation, expansion, and preservation, streamlining the production of therapies such as CAR-T cells and stem cell-based treatments. By minimizing manual intervention, they enhance scalability and regulatory compliance, addressing critical challenges in cell therapy production. As the demand for cell-based therapies grows, automated systems are becoming indispensable for meeting industry needs.

What Trends Are Driving Innovation in Cell Therapy Processing?

Several trends are shaping the market for automated and closed cell therapy processing systems. The rise of personalized medicine has fueled demand for systems capable of producing patient-specific therapies. Technological advancements in automation and robotics are enabling precise and reproducible workflows. The integration of data analytics and IoT features is enhancing process monitoring and quality control. Additionally, the increasing focus on decentralizing manufacturing through point-of-care production is driving the adoption of compact and portable systems.

How Are These Systems Enhancing the Cell Therapy Ecosystem?

Automated and closed systems are enhancing the cell therapy ecosystem by addressing bottlenecks in manufacturing and ensuring product safety and efficacy. These systems enable rapid scale-up of production, facilitating the commercialization of therapies for larger patient populations. Real-time monitoring and traceability features improve compliance with stringent regulatory standards. Moreover, the ability to standardize processes across facilities ensures consistent quality, reducing variability in therapy outcomes. These contributions are accelerating the adoption of cell-based treatments across diverse therapeutic areas.

What Drives the Growth in the Automated and Closed Cell Therapy Processing Systems Market?

The growth in the automated and closed cell therapy processing systems market is driven by increasing demand for cell-based therapies, advancements in automation technologies, and regulatory requirements for consistent manufacturing practices. The rising prevalence of cancer and genetic disorders has created a robust demand for scalable production solutions. Collaborations between biopharma companies and technology providers are accelerating innovation and expanding market access. Additionally, government funding and initiatives supporting cell therapy research are fostering the adoption of automated systems, ensuring sustained market growth.

SCOPE OF STUDY:

The report analyzes the Automated and Closed Cell Therapy Processing Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Workflow (Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow, Other Workflows); Type (Non-Stem Cell Therapy, Stem Cell Therapy)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

• BioSpherix(R), LLC
• Cellares Corporation
• Cytiva
• Danaher Corporation
• Fresenius Kabi AG
• Lonza, Inc.
• Miltenyi Biotec
• Sartorius AG
• Terumo Corporation
• Thermo Fisher Scientific, Inc.
• ThermoGenesis Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Automated and Closed Cell Therapy Processing Systems - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Cell and Gene Therapy Pipelines Drive Demand for Automated Processing
  • Need for Sterility and Standardization Boosts Adoption of Closed Systems
  • Reduction of Manual Errors Encourages Use of Automated Platforms
  • Expansion of GMP-Compliant Facilities Accelerates System Integration
  • Shortage of Skilled Technicians Supports Market for User-Friendly Automation
  • Advances in Integrated Bioprocessing Systems Improve Efficiency
  • Increased Investment by Biopharma Companies in In-House Manufacturing
  • Rising Adoption of Personalized Cell Therapies Requires Scalable Platforms
  • End-to-End Automation Enables Faster Turnaround and Cost Savings
  • Cloud-Based Data Logging Enhances Process Monitoring and Compliance
  • Miniaturization of Cell Processing Units Improves Flexibility and Portability
  • Expansion of CAR-T and T-Cell Therapies Accelerates Equipment Demand
  • Collaboration Between Biotech and Equipment Manufacturers Drives Innovation
  • Growing Focus on Patient-Specific Manufacturing Spurs Customizable Solutions
  • Regenerative Medicine Growth Expands Applications Beyond Oncology
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Automated and Closed Cell Therapy Processing Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Separation Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 5: World 6-Year Perspective for Separation Workflow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for Expansion Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 7: World 6-Year Perspective for Expansion Workflow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Apheresis Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World 6-Year Perspective for Apheresis Workflow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Fill- Finish Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 11: World 6-Year Perspective for Fill- Finish Workflow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 12: World Recent Past, Current & Future Analysis for Cryopreservation Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 13: World 6-Year Perspective for Cryopreservation Workflow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Workflows by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World 6-Year Perspective for Other Workflows by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Non-Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 17: World 6-Year Perspective for Non-Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 18: World Recent Past, Current & Future Analysis for Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 19: World 6-Year Perspective for Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Automated and Closed Cell Therapy Processing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 20: USA Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 21: USA 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
  • TABLE 22: USA Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 23: USA 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
• CANADA
  • TABLE 24: Canada Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 25: Canada 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
  • TABLE 26: Canada Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 27: Canada 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
• JAPAN
  • Automated and Closed Cell Therapy Processing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 28: Japan Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 29: Japan 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
  • TABLE 30: Japan Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 31: Japan 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
• CHINA
  • Automated and Closed Cell Therapy Processing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 32: China Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: China 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
  • TABLE 34: China Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 35: China 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
• EUROPE
  • Automated and Closed Cell Therapy Processing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 36: Europe Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 37: Europe 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • TABLE 38: Europe Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Europe 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
  • TABLE 40: Europe Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 41: Europe 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
• FRANCE
  • Automated and Closed Cell Therapy Processing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 42: France Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 43: France 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
  • TABLE 44: France Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: France 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
• GERMANY
  • Automated and Closed Cell Therapy Processing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 46: Germany Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 47: Germany 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
  • TABLE 48: Germany Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 49: Germany 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
• ITALY
  • TABLE 50: Italy Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Italy 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
  • TABLE 52: Italy Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 53: Italy 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
• UNITED KINGDOM
  • Automated and Closed Cell Therapy Processing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 54: UK Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 55: UK 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
  • TABLE 56: UK Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: UK 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
• REST OF EUROPE
  • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 59: Rest of Europe 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
  • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 61: Rest of Europe 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
• ASIA-PACIFIC
  • Automated and Closed Cell Therapy Processing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Asia-Pacific 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
  • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 65: Asia-Pacific 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030
• REST OF WORLD
  • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Workflow - Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 67: Rest of World 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Workflow - Percentage Breakdown of Value Sales for Separation Workflow, Expansion Workflow, Apheresis Workflow, Fill- Finish Workflow, Cryopreservation Workflow and Other Workflows for the Years 2025 & 2030
  • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Automated and Closed Cell Therapy Processing Systems by Type - Non-Stem Cell Therapy and Stem Cell Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Rest of World 6-Year Perspective for Automated and Closed Cell Therapy Processing Systems by Type - Percentage Breakdown of Value Sales for Non-Stem Cell Therapy and Stem Cell Therapy for the Years 2025 & 2030

IV. COMPETITION